California 2017-2018 Regular Session

California Assembly Bill ACR73

Introduced
4/24/17  
Introduced
4/24/17  
Refer
4/27/17  
Refer
4/27/17  
Engrossed
5/4/17  
Engrossed
5/4/17  
Refer
5/8/17  
Refer
5/8/17  
Enrolled
5/26/17  
Chaptered
6/6/17  
Chaptered
6/6/17  

Caption

Moyamoya Disease Awareness Day.

Impact

By declaring an official awareness day, ACR73 seeks to educate the public and medical community regarding Moyamoya disease, which is frequently misdiagnosed. With an occurrence rate of approximately one in every one to two million individuals, heightened awareness may lead to improved diagnostic capabilities and treatment options. Sections of the community may benefit from better understanding this condition, potentially leading to earlier interventions and reduced healthcare costs associated with untreated strokes and their aftermath.

Summary

Assembly Concurrent Resolution No. 73 (ACR73) was introduced to recognize May 6, 2017, as Moyamoya Disease Awareness Day in California. This resolution aims to bring attention to Moyamoya disease, a rare and progressively debilitating condition that affects blood flow to the brain. The name 'moyamoya' translates to 'puff of smoke' in Japanese, referencing the appearance of abnormal blood vessel formations that develop due to narrowed arteries. The resolution highlights the need for increased awareness and understanding of the disease, which can lead to serious complications such as strokes and cognitive impairments.

Sentiment

The sentiment surrounding ACR73 is predominantly positive, with a notable consensus on the necessity of raising awareness for an underrecognized medical condition. Supporters advocate for the resolution as an important step in promoting public health initiatives. The cooperative effort encapsulated in the resolution reflects a collective responsibility to address health disparities caused by lack of knowledge and research into rare diseases.

Contention

While the resolution was generally well received, some discourse may have arisen regarding attention allocation for rare diseases versus more common health concerns. Advocates for Moyamoya disease awareness emphasize the unique challenges faced by individuals suffering from such rare conditions, arguing that they deserve equal representation in public health discussions. This dialogue underlines a broader conversation on healthcare funding and resource distribution among different health issues.

Companion Bills

No companion bills found.

Similar Bills

LA SR3

Commends Tara MacInnes for her tireless works with Moyamoya disease and recognizes May 6, 2015, as Moyamoya Disease Awareness Day.

CT SB01091

An Act Designating Various Days And Weeks.